JMP Securities Reiterates “Market Outperform” Rating for Option Care Health (NASDAQ:OPCH)

JMP Securities reiterated their market outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a report published on Friday,Benzinga reports. JMP Securities currently has a $30.00 target price on the stock, down from their prior target price of $31.00.

OPCH has been the topic of a number of other reports. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial decreased their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, Barrington Research decreased their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $29.14.

Option Care Health Trading Down 0.6 %

Shares of Option Care Health stock opened at $23.99 on Friday. The firm has a market capitalization of $4.08 billion, a PE ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63. The firm’s 50-day moving average price is $23.10 and its 200 day moving average price is $27.69. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Several institutional investors have recently added to or reduced their stakes in OPCH. UMB Bank n.a. boosted its position in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC boosted its position in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its position in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares during the period. International Assets Investment Management LLC boosted its position in Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the period. Finally, Quarry LP boosted its position in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after buying an additional 2,628 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.